PhenixFIN Corp
PFXAnalytical Summary
PhenixFIN Corp shows mixed fundamentals. Further due diligence is recommended before making investment decisions.
7-Year Financial Trajectory
AnnualHealth Breakdown
Statement lens
Choose the reporting cadence, isolate a period range, or search directly for a metric.
| Metric | FY 2025 Sep 30, 2025 10-K ↗ | FY 2024 Sep 30, 2024 10-K ↗ | FY 2023 Sep 30, 2023 10-K ↗ | FY 2022 Sep 30, 2022 10-K ↗ | FY 2021 Sep 30, 2021 10-K ↗ | FY 2020 Sep 30, 2020 10-K ↗ | FY 2019 Sep 30, 2019 10-K ↗ |
|---|---|---|---|---|---|---|---|
| EPS Growth YoY (%) |
-77.4%
Weak
Weak
Year-over-year change in earnings per share
Optimal:
> 10%
|
-29.1%
Weak
Weak
Year-over-year change in earnings per share
Optimal:
> 10%
|
N/M | N/M | — | — | — |
| Net Income Growth YoY (%) |
-77.7%
Weak
Weak
Year-over-year change in net income |
-30.8%
Weak
Weak
Year-over-year change in net income |
N/M | — | — | — | — |
| FCF Growth YoY (%) | N/M | N/M |
21.5%
Good
Good
Year-over-year change in free cash flow |
N/M | — | — | — |
| EPS CAGR 3Y (%) | — |
166.9%
Excellent
Excellent
Compound annual EPS growth over 3 years |
— | — | — | — | — |
| Metric | FY 2025 Sep 30, 2025 10-K ↗ | FY 2024 Sep 30, 2024 10-K ↗ | FY 2023 Sep 30, 2023 10-K ↗ | FY 2022 Sep 30, 2022 10-K ↗ | FY 2021 Sep 30, 2021 10-K ↗ | FY 2020 Sep 30, 2020 10-K ↗ | FY 2019 Sep 30, 2019 10-K ↗ |
|---|---|---|---|---|---|---|---|
| FCF / Net Income (x) |
-16.20x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
0.86x
Caution
↓
Caution
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
-0.77x
Weak
Weak
Free cash flow relative to reported net income
Optimal:
> 1x
|
4.80x
Excellent
Excellent
Free cash flow relative to reported net income
Optimal:
> 1x
|
— | — | — |
| Metric | FY 2025 Sep 30, 2025 10-K ↗ | FY 2024 Sep 30, 2024 10-K ↗ | FY 2023 Sep 30, 2023 10-K ↗ | FY 2022 Sep 30, 2022 10-K ↗ | FY 2021 Sep 30, 2021 10-K ↗ | FY 2020 Sep 30, 2020 10-K ↗ | FY 2019 Sep 30, 2019 10-K ↗ |
|---|---|---|---|---|---|---|---|
| Return on Common Equity (%) (%) |
2.6%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
11.6%
Fair
↑
Fair
Improving
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
18.3%
Good
Good
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
-5.1%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
|
— | — | — |
| Metric | FY 2025 Sep 30, 2025 10-K ↗ | FY 2024 Sep 30, 2024 10-K ↗ | FY 2023 Sep 30, 2023 10-K ↗ | FY 2022 Sep 30, 2022 10-K ↗ | FY 2021 Sep 30, 2021 10-K ↗ | FY 2020 Sep 30, 2020 10-K ↗ | FY 2019 Sep 30, 2019 10-K ↗ |
|---|---|---|---|---|---|---|---|
| Net Income, GAAP (USD) | $4.16M | $18.62M | $26.92M | $-6.11M | — | — | — |
| Operating Cash Flow (USD) | $-67.33M | $16.10M | $-20.71M | $-29.30M | $95.13M | — | — |
Secondary lens
Benchmark Lens
Compare PFX against peers after checking the statement evidence.
Open lens
Benchmark Lens
Compare PFX against peers after checking the statement evidence.
Percentile Rankings
How PFX compares to all companies
Compare PFX with peers
Stack PFX against similar companies across every metric on this page.
north_east Open comparisonbar_chart Data from SEC EDGAR XBRL filings
Synced 1 week ago 7 years · 21 quarters